Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation

W. Brian Dalton, Eric Helmenstine, Noel Walsh, Lukasz P. Gondek, Dhanashree S. Kelkar, Abigail Read, Rachael Natrajan, Eric S. Christenson, Barbara Roman, Samarjit Das, Liang Zhao, Robert D. Leone, Daniel Shinn, Taylor Groginski, Anil K. Madugundu, Arun Patil, Daniel J. Zabransky, Arielle Medford, Justin Lee, Alex J. ColeMarc Rosen, Maya Thakar, Alexander Ambinder, Joshua Donaldson, Amy E. DeZern, Karen Cravero, David Chu, Rafael Madero-Marroquin, Akhilesh Pandey, Paula J. Hurley, Josh Lauring, Ben Park

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Cancer-associated mutations in the spliceosome gene SF3B1 create a neomorphic protein that produces aberrant mRNA splicing in hundreds of genes, but the ensuing biologic and therapeutic consequences of this missplicing are not well understood. Here we have provided evidence that aberrant splicing by mutant SF3B1 altered the transcriptome, proteome, and metabolome of human cells, leading to missplicing-associated downregulation of metabolic genes, decreased mitochondrial respiration, and suppression of the serine synthesis pathway. We also found that mutant SF3B1 induces vulnerability to deprivation of the nonessential amino acid serine, which was mediated by missplicing-associated downregulation of the serine synthesis pathway enzyme PHGDH. This vulnerability was manifest both in vitro and in vivo, as dietary restriction of serine and glycine in mice was able to inhibit the growth of SF3B1MUT xenografts. These findings describe a role for SF3B1 mutations in altered energy metabolism, and they offer a new therapeutic strategy against SF3B1MUT cancers.

Original languageEnglish (US)
JournalThe Journal of clinical investigation
Volume130
DOIs
StatePublished - Aug 8 2019

Fingerprint

Serine
Mutation
Down-Regulation
Spliceosomes
Mitochondrial Genes
Metabolome
Proteome
Transcriptome
Heterografts
Glycine
Energy Metabolism
Genes
Neoplasms
Respiration
Amino Acids
Messenger RNA
Enzymes
Therapeutics
Growth
Proteins

Keywords

  • Amino acid metabolism
  • Cancer
  • Metabolism
  • Oncology

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Dalton, W. B., Helmenstine, E., Walsh, N., Gondek, L. P., Kelkar, D. S., Read, A., ... Park, B. (2019). Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation. The Journal of clinical investigation, 130. https://doi.org/10.1172/JCI125022

Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation. / Dalton, W. Brian; Helmenstine, Eric; Walsh, Noel; Gondek, Lukasz P.; Kelkar, Dhanashree S.; Read, Abigail; Natrajan, Rachael; Christenson, Eric S.; Roman, Barbara; Das, Samarjit; Zhao, Liang; Leone, Robert D.; Shinn, Daniel; Groginski, Taylor; Madugundu, Anil K.; Patil, Arun; Zabransky, Daniel J.; Medford, Arielle; Lee, Justin; Cole, Alex J.; Rosen, Marc; Thakar, Maya; Ambinder, Alexander; Donaldson, Joshua; DeZern, Amy E.; Cravero, Karen; Chu, David; Madero-Marroquin, Rafael; Pandey, Akhilesh; Hurley, Paula J.; Lauring, Josh; Park, Ben.

In: The Journal of clinical investigation, Vol. 130, 08.08.2019.

Research output: Contribution to journalArticle

Dalton, WB, Helmenstine, E, Walsh, N, Gondek, LP, Kelkar, DS, Read, A, Natrajan, R, Christenson, ES, Roman, B, Das, S, Zhao, L, Leone, RD, Shinn, D, Groginski, T, Madugundu, AK, Patil, A, Zabransky, DJ, Medford, A, Lee, J, Cole, AJ, Rosen, M, Thakar, M, Ambinder, A, Donaldson, J, DeZern, AE, Cravero, K, Chu, D, Madero-Marroquin, R, Pandey, A, Hurley, PJ, Lauring, J & Park, B 2019, 'Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation', The Journal of clinical investigation, vol. 130. https://doi.org/10.1172/JCI125022
Dalton, W. Brian ; Helmenstine, Eric ; Walsh, Noel ; Gondek, Lukasz P. ; Kelkar, Dhanashree S. ; Read, Abigail ; Natrajan, Rachael ; Christenson, Eric S. ; Roman, Barbara ; Das, Samarjit ; Zhao, Liang ; Leone, Robert D. ; Shinn, Daniel ; Groginski, Taylor ; Madugundu, Anil K. ; Patil, Arun ; Zabransky, Daniel J. ; Medford, Arielle ; Lee, Justin ; Cole, Alex J. ; Rosen, Marc ; Thakar, Maya ; Ambinder, Alexander ; Donaldson, Joshua ; DeZern, Amy E. ; Cravero, Karen ; Chu, David ; Madero-Marroquin, Rafael ; Pandey, Akhilesh ; Hurley, Paula J. ; Lauring, Josh ; Park, Ben. / Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation. In: The Journal of clinical investigation. 2019 ; Vol. 130.
@article{7cc57ef09c57456099c66db852c41ba1,
title = "Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation",
abstract = "Cancer-associated mutations in the spliceosome gene SF3B1 create a neomorphic protein that produces aberrant mRNA splicing in hundreds of genes, but the ensuing biologic and therapeutic consequences of this missplicing are not well understood. Here we have provided evidence that aberrant splicing by mutant SF3B1 altered the transcriptome, proteome, and metabolome of human cells, leading to missplicing-associated downregulation of metabolic genes, decreased mitochondrial respiration, and suppression of the serine synthesis pathway. We also found that mutant SF3B1 induces vulnerability to deprivation of the nonessential amino acid serine, which was mediated by missplicing-associated downregulation of the serine synthesis pathway enzyme PHGDH. This vulnerability was manifest both in vitro and in vivo, as dietary restriction of serine and glycine in mice was able to inhibit the growth of SF3B1MUT xenografts. These findings describe a role for SF3B1 mutations in altered energy metabolism, and they offer a new therapeutic strategy against SF3B1MUT cancers.",
keywords = "Amino acid metabolism, Cancer, Metabolism, Oncology",
author = "Dalton, {W. Brian} and Eric Helmenstine and Noel Walsh and Gondek, {Lukasz P.} and Kelkar, {Dhanashree S.} and Abigail Read and Rachael Natrajan and Christenson, {Eric S.} and Barbara Roman and Samarjit Das and Liang Zhao and Leone, {Robert D.} and Daniel Shinn and Taylor Groginski and Madugundu, {Anil K.} and Arun Patil and Zabransky, {Daniel J.} and Arielle Medford and Justin Lee and Cole, {Alex J.} and Marc Rosen and Maya Thakar and Alexander Ambinder and Joshua Donaldson and DeZern, {Amy E.} and Karen Cravero and David Chu and Rafael Madero-Marroquin and Akhilesh Pandey and Hurley, {Paula J.} and Josh Lauring and Ben Park",
year = "2019",
month = "8",
day = "8",
doi = "10.1172/JCI125022",
language = "English (US)",
volume = "130",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",

}

TY - JOUR

T1 - Hotspot SF3B1 mutations induce metabolic reprogramming and vulnerability to serine deprivation

AU - Dalton, W. Brian

AU - Helmenstine, Eric

AU - Walsh, Noel

AU - Gondek, Lukasz P.

AU - Kelkar, Dhanashree S.

AU - Read, Abigail

AU - Natrajan, Rachael

AU - Christenson, Eric S.

AU - Roman, Barbara

AU - Das, Samarjit

AU - Zhao, Liang

AU - Leone, Robert D.

AU - Shinn, Daniel

AU - Groginski, Taylor

AU - Madugundu, Anil K.

AU - Patil, Arun

AU - Zabransky, Daniel J.

AU - Medford, Arielle

AU - Lee, Justin

AU - Cole, Alex J.

AU - Rosen, Marc

AU - Thakar, Maya

AU - Ambinder, Alexander

AU - Donaldson, Joshua

AU - DeZern, Amy E.

AU - Cravero, Karen

AU - Chu, David

AU - Madero-Marroquin, Rafael

AU - Pandey, Akhilesh

AU - Hurley, Paula J.

AU - Lauring, Josh

AU - Park, Ben

PY - 2019/8/8

Y1 - 2019/8/8

N2 - Cancer-associated mutations in the spliceosome gene SF3B1 create a neomorphic protein that produces aberrant mRNA splicing in hundreds of genes, but the ensuing biologic and therapeutic consequences of this missplicing are not well understood. Here we have provided evidence that aberrant splicing by mutant SF3B1 altered the transcriptome, proteome, and metabolome of human cells, leading to missplicing-associated downregulation of metabolic genes, decreased mitochondrial respiration, and suppression of the serine synthesis pathway. We also found that mutant SF3B1 induces vulnerability to deprivation of the nonessential amino acid serine, which was mediated by missplicing-associated downregulation of the serine synthesis pathway enzyme PHGDH. This vulnerability was manifest both in vitro and in vivo, as dietary restriction of serine and glycine in mice was able to inhibit the growth of SF3B1MUT xenografts. These findings describe a role for SF3B1 mutations in altered energy metabolism, and they offer a new therapeutic strategy against SF3B1MUT cancers.

AB - Cancer-associated mutations in the spliceosome gene SF3B1 create a neomorphic protein that produces aberrant mRNA splicing in hundreds of genes, but the ensuing biologic and therapeutic consequences of this missplicing are not well understood. Here we have provided evidence that aberrant splicing by mutant SF3B1 altered the transcriptome, proteome, and metabolome of human cells, leading to missplicing-associated downregulation of metabolic genes, decreased mitochondrial respiration, and suppression of the serine synthesis pathway. We also found that mutant SF3B1 induces vulnerability to deprivation of the nonessential amino acid serine, which was mediated by missplicing-associated downregulation of the serine synthesis pathway enzyme PHGDH. This vulnerability was manifest both in vitro and in vivo, as dietary restriction of serine and glycine in mice was able to inhibit the growth of SF3B1MUT xenografts. These findings describe a role for SF3B1 mutations in altered energy metabolism, and they offer a new therapeutic strategy against SF3B1MUT cancers.

KW - Amino acid metabolism

KW - Cancer

KW - Metabolism

KW - Oncology

UR - http://www.scopus.com/inward/record.url?scp=85072150513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072150513&partnerID=8YFLogxK

U2 - 10.1172/JCI125022

DO - 10.1172/JCI125022

M3 - Article

C2 - 31393856

AN - SCOPUS:85072150513

VL - 130

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

ER -